个体化与标准血压管理策略对高危大手术患者术后器官功能障碍的影响:一项随机临床试验
INPRESS多中心随机对照试验纳入298例术后并发症风险增高的大手术成人患者,比较个体化血压管理(目标收缩压维持在参考值10%以内)与标准管理(收缩压低于80 mm Hg或低于参考值40%时治疗)。个体化组术后7天主要终点事件发生率为38.1%,低于标准组的51.7%(RR 0.73,95%CI 0.56-0.94,P=.02),术后30天器官功能障碍风险亦降低(校正HR 0.66,95%CI 0.52-0.84,P=.001)。
要点
- 个体化血压管理组术后7天主要复合终点发生率为38.1%,标准管理组为51.7%(RR 0.73,95%CI 0.56-0.94,P=.02)。
- 个体化组术后30天器官功能障碍发生率为46.3%,标准组为63.4%(校正HR 0.66,95%CI 0.52-0.84,P=.001)。
- 两组严重不良事件或30天死亡率无显著差异。
核心结论
- 在主要为腹部手术且术后风险增高的患者中,与标准管理相比,以个体化收缩压为目标的管理降低了术后器官功能障碍风险。
研究设计与样本
- INPRESS研究为多中心、随机、平行组临床试验,在9家法国大学与非大学医院开展。
- 纳入298例术后并发症风险增高、术前急性肾损伤风险指数III级或以上、接受全身麻醉下持续2小时或以上大手术的成人患者,入组时间为2012年12月4日至2016年8月28日,末次随访为2016年9月28日。
- 个体化策略目标为收缩压维持在参考值(即患者静息收缩压)10%以内;标准策略为收缩压低于80 mm Hg或低于参考值40%时进行治疗,干预持续至术后4小时。
- 主要终点为术后第7天全身炎症反应综合征及肾脏、呼吸、心血管、凝血、神经系统至少1个器官系统功能障碍的复合终点。
- 292例患者完成试验并纳入改良意向性分析,平均(SD)年龄70(7)岁,女性44例(15.1%)。
主要发现
- 主要终点事件在个体化治疗组147例中发生56例(38.1%),标准治疗组145例中发生75例(51.7%)(相对风险0.73,95%CI 0.56-0.94,P=.02;绝对风险差异-14%,95%CI -25%至-2%)。
- 术后30天器官功能障碍在个体化治疗组68例(46.3%)、标准治疗组92例(63.4%)中发生(校正风险比0.66,95%CI 0.52-0.84,P=.001)。
- 两组严重不良事件或30天死亡率无显著差异。
关键数值与推荐
- 个体化管理策略目标为收缩压维持在参考值10%以内。
- 标准管理策略为收缩压低于80 mm Hg或低于参考值40%时进行治疗。
- 主要终点为术后第7天全身炎症反应综合征及至少1个器官系统功能障碍的复合终点。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Perioperative hypotension is associated with an increase in postoperative morbidity and mortality, but the appropriate management strategy remains uncertain. OBJECTIVE: To evaluate whether an individualized blood pressure management strategy tailored to individual patient physiology could reduce postoperative organ dysfunction. DESIGN, SETTING, AND PARTICIPANTS: The Intraoperative Norepinephrine to Control Arterial Pressure (INPRESS) study was a multicenter, randomized, parallel-group clinical trial conducted in 9 French university and nonuniversity hospitals. Adult patients (n = 298) at increased risk of postoperative complications with a preoperative acute kidney injury risk index of class III or higher (indicating moderate to high risk of postoperative kidney injury) undergoing major surgery lasting 2 hours or longer under general anesthesia were enrolled from December 4, 2012, through August 28, 2016 (last follow-up, September 28, 2016). INTERVENTIONS: Individualized management strategy aimed at achieving a systolic blood pressure (SBP) within 10% of the reference value (ie, patient's resting SBP) or standard management strategy of treating SBP less than 80 mm Hg or lower than 40% from the reference value during and for 4 hours following surgery. MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of systemic inflammatory response syndrome and dysfunction of at least 1 organ system of the renal, respiratory, cardiovascular, coagulation, and neurologic systems by day 7 after surgery. Secondary outcomes included the individual components of the primary outcome, durations of ICU and hospital stay, adverse events, and all-cause mortality at 30 days after surgery. RESULTS: Among 298 patients who were randomized, 292 patients completed the trial (mean [SD] age, 70 [7] years; 44 [15.1%] women) and were included in the modified intention-to-treat analysis. The primary outcome event occurred in 56 of 147 patients (38.1%) assigned to the individualized treatment strategy vs 75 of 145 patients (51.7%) assigned to the standard treatment strategy (relative risk, 0.73; 95% CI, 0.56 to 0.94; P = .02; absolute risk difference, -14%, 95% CI, -25% to -2%). Sixty-eight patients (46.3%) in the individualized treatment group and 92 (63.4%) in the standard treatment group had postoperative organ dysfunction by day 30 (adjusted hazard ratio, 0.66; 95% CI, 0.52 to 0.84; P = .001). There were no significant between-group differences in severe adverse events or 30-day mortality. CONCLUSIONS AND RELEVANCE: Among patients predominantly undergoing abdominal surgery who were at increased postoperative risk, management targeting an individualized systolic blood pressure, compared with standard management, reduced the risk of postoperative organ dysfunction. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01536470.
引用
- Futier E, Lefrant JY, Guinot PG, et al. Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2017. PMID: 28973220. doi:10.1001/jama.2017.14172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。